問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2020-01-01 - 2024-08-08
Condition/Disease
Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities
Test Drug
Tirzepatide
Participate Sites5Sites
Terminated5Sites
2019-02-15 - 2021-04-22
Type 2 Diabetes Mellitus
LY3298176
Participate Sites9Sites
Terminated9Sites
2019-04-01 - 2022-12-15
2018-11-01 - 2019-12-31
Moderate to Severe Atopic Dermatitis
Baricitinib (LY3009104)
Division of Dermatology
-
Participate Sites0Sites
2022-12-01 - 2025-12-31
Participate Sites4Sites
Recruiting4Sites
2023-07-31 - 2026-05-27
Participate Sites8Sites
Recruiting8Sites
2022-05-01 - 2023-02-23
Participate Sites2Sites
Recruiting2Sites
2021-11-01 - 2026-02-28
Recruiting3Sites
Terminated2Sites
2023-12-12 - 2024-07-22
Participate Sites1Sites
Recruiting1Sites
全部
